Allergan plc (NYSE:AGN)

186.37
Delayed Data
As of Dec 06
 +0.29 / +0.16%
Today’s Change
114.27
Today|||52-Week Range
186.91
+39.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line3.9B15.0B-4.7B-5.1B
 
 
 
 
 
Depreciation5.6B6.6B7.4B6.7B
 
 
 
 
 
Total Other Cash Flow3.7B-18.0B10.0B6.5B
 
 
 
 
 
Funds From Operations5.8B2.2B4.9B6.9B
 
 
 
 
 
Funds From/For Other Operating Expenses1.3B726.5M-933.9M1.3B
 
 
 
 
 
Net Cash Flow - Operating Activities4.5B1.4B5.9B5.6B
 
 
 
 
 
 
InvestingIncrease In Investments-24.3M-15.7B-9.8B-2.5B
 
 
 
 
 
Decrease In Investments883.0M0.000.00--
 
 
Capital Expenditures-454.9M-331.4M-349.9M-253.5M
 
 
 
 
 
Fixed Asset Disposal140.1M33.8B7.1M30.4M
 
 
 
 
 
Net Assets From Acquisitions -37.5B-1.2B-5.3B0.00
 
 
 
 
Other Investing - Uses0.000.000.00-466.0M
 
 
Other Investing - Sources--7.8B15.2B6.3B
 
 
 
 
Net Cash Flow Investing-37.1B24.3B-878.0M3.1B
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings29.8B1.1B3.5B2.6B
 
 
 
 
 
Long Term Debt Reduction-5.1B-10.8B-6.4B-8.8B
 
 
 
 
 
Net Proceeds Stock Sale9.2B172.1M183.4M102.4M
 
 
 
 
 
Common Preferred Redeemed-118.0M-15.1B-493.0M-2.8B
 
 
 
 
 
Common Dividends0.000.000.00-1.0B
 
 
Cash Dividends Paid - Total-208.1M-278.4M-1.2B-1.0B
 
 
 
 
 
Other Sources - Financing76.1M20.4M0.00465.5M
 
 
 
 
Other Uses - Financing230.1M161.1M511.6M264.9M
 
 
 
 
 
Net Cash Flow - Financing33.4B-25.1B-4.9B-9.7B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-6.5M-8.5M21.4M4.7M
 
 
 
 
 
 
Net Change In Cash852.5M636.5M71.8M-941.5M